ConductScience.org, home

Gene · 5921

NIH grants2,330

NIH grants whose papers are about the gene, through NIH's grant-paper links.

261 to 280 of 2,330

Download this page as JSON
GrantTitleRASA1 papersNewest fiscal year
R50CA211506Preclinical Models for Cancer Therapeutic Development12025
R50CA233164Developing Human Induced Pluripotent Stem Cell Precision Oncology Models12025
RM1HG009490Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease12025
T15LM007088Research Training in Biomedical Informatics and Data Science at Oregon Health & Science University12025
T15LM007442University of Washington Biomedical Informatics and Data Science Research Training Program12025
T15LM007450Vanderbilt Biomedical Informatics Training Program12025
T32AG000029Behavior and Physiology in Aging12025
T32AG000266Training in Basic Research on Aging and Age-Related Disease12025
T32AI007413Research Training in Experimental Immunology12025
T32CA009109Cancer Research Training Program: From Molecular Mechanisms to Therapeutic Strategies12025
T32CA009592Microenvironmental Influences in Cancer12025
T32CA009676Training Program in Tumor Microenvironment12025
T32CA154274Training Grant in Cancer Biology12025
T32CA196561Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology12025
T32DK007198Multidisciplinary Training in Digestive Diseases12025
T32EB001631Biomedical Imaging for Clinician Scientists12025
T32EY007145Training Program in the Molecular Bases of Eye Disease12025
T32GM008243UCLA Medical Genetics Training Program12025
T32GM082773T32 training grant in medical genetics.12025
T32GM132083Tri-Institutional PhD Program in Computational Biology & Medicine12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5921/grants?page=14